Opinion
Video
Author(s):
Benjamin A. Weinberg, MD, presents the case of a 35-year-old man with oligometastatic disease, and the panel provides insights on treatment decisions.
The OncFive: Top Oncology Articles for the Week of 12/15
Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH
NGS and ctDNA Testing Guide Treatment Selection and Sequencing in mCRC
Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements
The Microbiome and Colon Cancer: Dietary Influence on Incidence, Morbidity, and Mortality
Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC
Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC
Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab
Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma